Table 1.
Patient Characteristics
| PH | CCC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Total (n = 180) | Inpatient (n = 88) | pa | Outpatient (n = 92) | Total (n = 179) | Inpatient (n = 90) | pb | Outpatient (n = 92) | pc | pd |
| Median age, years (range) | 57 (24–83) | 56.5 (24–83) | 0.8458 | 57 (25–75) | 54 (20–88) | 54 (20–88) | 0.6875 | 55 (28–72) | 0.0818 | |
| Sex, n (%) | ||||||||||
| Female | 79 (44) | 41 (47) | 0.4750 | 38 (41) | 78 (44) | 40 (45) | 0.7135 | 38 (42) | 0.9523 | |
| Male | 101 (56) | 47 (53) | 54 (59) | 101 (56) | 49 (55) | 52 (58) | ||||
| Race, n (%) | 0.0001 | 0.2764 | <0.0001 | |||||||
| Asian | 3 (2) | 0 (0) | 3 (3) | 11 (6) | 7 (8) | 4 (4) | ||||
| Black | 69 (39) | 47 (55) | 22 (24) | 29 (17) | 10 (11) | 19 (22) | ||||
| Hispanic | 63 (36) | 24 (28) | 39 (42) | 20 (11) | 11 (13) | 9 (10) | ||||
| White | 41 (23) | 14 (17) | 27 (29) | 115 (66) | 59 (68) | 56 (64) | ||||
| Health insurance coverage, n (%) | <0.0001 | 1.000 | <0.0001 | |||||||
| Not reported | 84 (47) | 22 (25) | 62 (67) | 1 (1) | 0 (0) | 1 (1) | ||||
| Reported | 96 (53) | 66 (75) | 30 (33) | 178 (99) | 89 (100) | 89 (99) | ||||
| CAGE questionnaire results, n (%) | 0.6622 | 0.3702 | 1.000 | |||||||
| Negative | 77 (76) | 36 (78) | 41 (75) | 115 (76) | 50 (79) | 65 (73) | ||||
| Positive | 24 (24) | 10 (22) | 14 (25) | 37 (24) | 13 (21) | 24 (27) | ||||
| Primary cancer, n (%) | 0.0035 | 0.247 | 0.1142 | |||||||
| Gastrointestinal | 58 (46) | 25 (42) | 33 (50) | 38 (31) | 21 (37) | 17 (27) | ||||
| Head/neck | 25 (20) | 15 (25) | 10 (15) | 31 (26) | 10 (18) | 21 (33) | ||||
| Urological | 14 (11) | 3 (5) | 11 (17) | 14 (12) | 8 (4) | 6 (9) | ||||
| Breast | 16 (13) | 5 (8) | 11 (17) | 17 (14) | 6 (10) | 11 (17) | ||||
| Hematological | 8 (6) | 7 (12) | 1 (1) | 9 (7) | 6 (10) | 3 (5) | ||||
| Gynecological | 4 (3) | 4 (7) | 0 (0) | 12 (10) | 6 (10) | 6 (9) | ||||
| Median time from consultation to ESAS follow-up, days (range); number of patientsd | 124, 4.5 (0, 119) | 64, 1 (0,10) | <0.0001 | 60, 29 (1, 119) | 163, 9 (1, 275) | 88, 3 (1,65) | <0.0001 | 75, 21 (1, 275) | 0.6812 | 0.0006 |
| Median overall survival time from consultation, days (95% CI) | 199 (116, 243) | 67 (31, 123) | <0.0001 | 473 (205, 699) | 77 (54, 132) | 34 (24, 51) | <0.0001 | 245 (152, 491) | 0.013 | 0.3408 |
a
Inpatients versus outpatients at the PH.
b
Inpatients versus outpatients at the CCC.
c
Total PH versus CCC.
d
Between the PH and CCC for outpatient care.
e
Considering patients only with ESAS at follow-up.
PH, public hospital; CCC, comprehensive cancer center; CI, confidence interval; ESAS, Edmonton Symptom Assessment Scale.
Bold p-values are significant values only.